Published in Dig Dis Sci on September 01, 1993
Ghrelin and Gastric Emptying in Children With Functional Dyspepsia (GHR) | NCT01591174
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain (2009) 5.62
Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol (2006) 4.34
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci (1998) 3.74
American Gastroenterological Association technical review on constipation. Gastroenterology (2013) 3.27
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci (2002) 2.46
Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum (2009) 2.24
Sex differences in irritable bowel syndrome in Japanese university students. J Gastroenterol (2006) 2.23
Dyspepsia: is a trial of therapy appropriate? CMAJ (1995) 2.19
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut (2000) 2.09
Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut (1999) 2.08
The epidemiology of irritable bowel syndrome. Clin Epidemiol (2014) 2.06
International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol (2009) 2.06
Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract (2004) 2.03
Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum (2006) 2.01
Psychosocial aspects of the functional gastrointestinal disorders. Gut (1999) 1.99
A genetic test which can be used to diagnose adult-type hypolactasia in children. Gut (2004) 1.95
Validation of a specific quality of life questionnaire for functional digestive disorders. Gut (1999) 1.93
Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. CMAJ (1999) 1.89
Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol (2006) 1.87
Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology (2014) 1.86
Understanding fibromyalgia: lessons from the broader pain research community. J Pain (2009) 1.73
Subtotal colectomy with antiperistaltic cecoproctostomy for selected patients with slow transit constipation-from Chinese report. Int J Colorectal Dis (2008) 1.67
Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut (2005) 1.67
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut (2001) 1.66
Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med (2011) 1.63
Long term benefits of hypnotherapy for irritable bowel syndrome. Gut (2003) 1.63
Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am (2008) 1.59
Endoscopic "no hole" full-thickness biopsy of the stomach to detect myenteric ganglia. Gastrointest Endosc (2008) 1.55
IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53
Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52
Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Dig Dis Sci (2000) 1.50
Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut (1998) 1.48
Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study. Pain (2007) 1.42
Management of irritable bowel syndrome. Postgrad Med J (2003) 1.40
The bother of anal incontinence and St. Mark's Incontinence Score. Tech Coloproctol (2015) 1.39
Prevalence and Self-recognition of Chronic Constipation: Results of an Internet Survey. J Neurogastroenterol Motil (2016) 1.38
Functional disorders of the anus and rectum. Gut (1999) 1.38
Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol (2008) 1.35
Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32
Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol (2009) 1.32
Irritable bowel syndrome: diagnosis and management. BMJ (2006) 1.31
Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol (2008) 1.31
Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut (1999) 1.31
Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci (2002) 1.28
Effects of gender and menstrual cycle on colonic transit time in healthy subjects. Korean J Intern Med (2003) 1.26
A population-based study on bowel habits in a Korean community: prevalence of functional constipation and self-reported constipation. Dig Dis Sci (2006) 1.25
Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial. World J Gastroenterol (2005) 1.25
The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil (2010) 1.24
Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci (2007) 1.20
Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol (2014) 1.20
Prevalence of anal incontinence according to age and gender: a systematic review and meta-regression analysis. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.19
A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther (2011) 1.18
Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol (2010) 1.18
Sphincter of Oddi Function and Risk Factors for Dysfunction. Front Nutr (2017) 1.17
The effect of Aloe ferox Mill. in the treatment of loperamide-induced constipation in Wistar rats. BMC Gastroenterol (2010) 1.16
Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med (2007) 1.15
Functional disorders of the biliary tract and pancreas. Gut (1999) 1.14
Onset and risk factors for fecal incontinence in a US community. Am J Gastroenterol (2009) 1.14
Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol (2014) 1.14
Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci (1999) 1.14
Epidemiology and burden of chronic constipation. Can J Gastroenterol (2011) 1.13
Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci (2002) 1.12
Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut (2001) 1.11
Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil (2010) 1.10
Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol (2011) 1.10
Globus pharyngeus: a review of its etiology, diagnosis and treatment. World J Gastroenterol (2012) 1.10
Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med (2003) 1.10
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut (2008) 1.09
Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. World J Gastroenterol (2013) 1.07
Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian J Psychiatry (2013) 1.07
Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil (2010) 1.07
Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol (2007) 1.07
Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut (1994) 1.07
Mind/Body psychological treatments for irritable bowel syndrome. Evid Based Complement Alternat Med (2008) 1.07
The relationship between daily life stress and gastrointestinal symptoms in women with irritable bowel syndrome. J Behav Med (1997) 1.06
Pathophysiological and psychosocial study in patients with functional vomiting. J Neurogastroenterol Motil (2010) 1.06
Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci (1997) 1.06
Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol (2008) 1.06
Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology (2010) 1.05
Cluster analysis of symptoms and health seeking behaviour differentiates subgroups of patients with severe irritable bowel syndrome. Gut (2003) 1.04
PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity. Neurogastroenterol Motil (2010) 1.03
Longitudinal direct medical costs associated with constipation in women. Aliment Pharmacol Ther (2010) 1.03
Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil (2011) 1.03
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 1.03
Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J Gastroenterol (2012) 1.02
Health status and management of chronic non-specific abdominal complaints in general practice. Br J Gen Pract (2000) 1.02
Novel mechanisms in functional dyspepsia. World J Gastroenterol (2006) 1.02
Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes. J Neurogastroenterol Motil (2010) 1.01
Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol (2013) 1.01
Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Br J Gen Pract (2006) 1.01
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol (2006) 1.00
Irritable bowel syndrome. Diagnosis in the managed care era. Dig Dis Sci (1997) 1.00
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Comparative genomics of the eukaryotes. Science (2000) 26.62
Towards positive diagnosis of the irritable bowel. Br Med J (1978) 12.79
Diagnostic value of esophageal studies in patients with angina-like chest pain and normal coronary angiograms. Ann Intern Med (1996) 8.91
Functional bowel disorders in apparently healthy people. Gastroenterology (1980) 8.52
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Convergent domestication of cereal crops by independent mutations at corresponding genetic Loci. Science (1995) 5.52
Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology (1998) 5.34
Randomized clinical trial of virtual reality simulation for laparoscopic skills training. Br J Surg (2004) 5.19
Inhibition of JNK activation through NF-kappaB target genes. Nature (2001) 5.03
A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Trend tests for case-control studies of genetic markers: power, sample size and robustness. Hum Hered (2002) 4.64
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest (1977) 3.89
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
Synthesis and fungicidal activity against Rhizoctonia solani of 2-alkyl (Alkylthio)-5-pyrazolyl-1,3,4-oxadiazoles (Thiadiazoles). J Agric Food Chem (2000) 3.78
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem (1996) 3.63
Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem (1996) 3.63
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet (1995) 3.59
Isoform-specific 3'-untranslated sequences sort alpha-cardiac and beta-cytoplasmic actin messenger RNAs to different cytoplasmic compartments. J Cell Biol (1993) 3.49
Value of necropsy in acquired immunodeficiency syndrome. Lancet (1988) 3.39
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients. Aliment Pharmacol Ther (2014) 3.37
Single-cell electroporation for gene transfer in vivo. Neuron (2001) 3.15
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
RAG mutations in human B cell-negative SCID. Science (1996) 3.03
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol (2000) 2.95
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics (1994) 2.88
Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A (1999) 2.88
Effects of dog ownership in early childhood on immune development and atopic diseases. Clin Exp Allergy (2008) 2.86
Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol (1996) 2.86
A comparison of work-sampling and time-and-motion techniques for studies in health services research. Health Serv Res (1993) 2.83
Structural and magnetic phase diagram of CeFeAsO(1- x)F(x) and its relation to high-temperature superconductivity. Nat Mater (2008) 2.83
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity (2001) 2.77
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
Identification and analysis of PH domain-containing targets of phosphatidylinositol 3-kinase using a novel in vivo assay in yeast. EMBO J (1998) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Superconductivity at 41 K and its competition with spin-density-wave instability in layered CeO1-xFxFeAs. Phys Rev Lett (2008) 2.72
Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut (2000) 2.71
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis (2000) 2.63
Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med (1997) 2.59
Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol (1995) 2.53
Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci (1980) 2.53
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys (1999) 2.47
Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microbiol (1996) 2.46
Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics (1996) 2.44
Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci (1982) 2.43
Health status by gastrointestinal diagnosis and abuse history. Gastroenterology (1996) 2.41
The vacB gene required for virulence in Shigella flexneri and Escherichia coli encodes the exoribonuclease RNase R. J Biol Chem (1998) 2.41
Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology (2001) 2.41
Mutations in the essential spindle checkpoint gene bub1 cause chromosome missegregation and fail to block apoptosis in Drosophila. J Cell Biol (1999) 2.41
Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J Biol Chem (2000) 2.39
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Spontaneous breaking of time-reversal symmetry in the pseudogap state of a high-Tc superconductor. Nature (2002) 2.37
Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 2.36
Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology (2001) 2.36
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut (2006) 2.33
Bile duct injury during laparoscopic cholecystectomy: a prospective nationwide series. J Am Coll Surg (1997) 2.33
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol (2001) 2.30
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J (1998) 2.29
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science (1999) 2.21
Hypoxia inducible factors in cancer stem cells. Br J Cancer (2010) 2.21
Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut (2005) 2.20
Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci (2001) 2.19
Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet (1995) 2.18
Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18